ORPP logo
Image from Google Jackets

Primer on Multiple Sclerosis.

By: Material type: TextTextPublisher: Oxford : Oxford University Press, Incorporated, 2016Copyright date: ©2016Edition: 2nd edDescription: 1 online resource (613 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9780199341023
Subject(s): Genre/Form: Additional physical formats: Print version:: Primer on Multiple SclerosisDDC classification:
  • 616.8/34
LOC classification:
  • RC377
Online resources:
Contents:
Cover -- Primer on Multiple Sclerosis -- Copyright -- Dedication -- Contents -- Foreword -- Preface -- Contributors -- Part I: Historical Background -- 1. The History of Multiple Sclerosis: From the Age of Description to the Age of Therapy -- Part II: Basic Science -- 2. Genetics and Epidemiology of Multiple Sclerosis -- 3. Neurophysiology of Multiple Sclerosis -- 4. Immunology of Multiple Sclerosis -- 5. Taking a Microscopic Look at Multiple Sclerosis -- Part III: Diagnosis &amp -- Prognosis -- 6. Diagnosis of Multiple Sclerosis -- 7. Neuroimaging in Multiple Sclerosis -- 8. The Importance and Utility of Cerebrospinal Fluid Evaluation in the Diagnosis of Central Demyelinating Diseases -- 9. Evoked Potentials -- 10. Temporal and Clinical Course of Multiple Sclerosis -- 11. Outcome Measures in Multiple Sclerosis -- Part IV: Clinical Manifestations -- 12. Neuro-ophthalmologic Manifestations of Multiple Sclerosis -- 13. Cerebellar and Brainstem Dysfunction in Multiple Sclerosis -- 14. Disorders of Mobility in Multiple Sclerosis -- 15. Management of Urinary and Bowel Dysfunction in Multiple Sclerosis -- 16. Assessment and Treatment of Sexual Dysfunction in Multiple Sclerosis -- 17. Gender and Reproductive Issues in Multiple Sclerosis -- 18. Cognitive Impairment and Mood Disturbances -- 19. Multiple Sclerosis and Pain -- 20. Fatigue in Multiple Sclerosis -- 21. Sleep Disorders in Multiple Sclerosis -- 22. Pediatric Multiple Sclerosis -- 23. Neuromyelitis Optica Spectrum Disorders -- 24. Multiple Sclerosis Nursing -- Part V: Therapeutics -- 25. Immunomodulatory Agents for Relapsing-Remitting Multiple Sclerosis -- 26. Relapses, Immunosuppressive and Novel Therapies -- 27. Complementary and Alternative Medicine in Multiple Sclerosis -- Part VI: Psychosocial Issues.
28. Living with Multiple Sclerosis: The Psychosocial Challenges for Patients and Their Families -- 29. Employment and Career Development Considerations -- 30. Legal Planning Issues -- Part VII: Research -- 31. Issues in the Design and Interpretation of Multiple Sclerosis Clinical Trials -- 32. Basic Science in Multiple Sclerosis Research: Progress and Promise -- Index.
Summary: In this second edition of Primer on Multiple Sclerosis, the latest updates on therapeutics will be provided, including new medications that have been FDA- approved since the first edition. New diagnostic criteria is included, as well as any advances made in current diagnostic techniques, e.g. new imaging metrics. Important new information in the basic sciences and pathophysiology of MS are provided as well as newer epidemiologic studies. Treatment algorithms for common symptoms will be expanded, as well as any new guidelines for switching medications for Disease Modifying treatment "failures". The chapter on alternative and complimentary therapies will discuss new research on CCSVI. The chapter on legal issues will include information on the putative effect of the Affordable Health Care Act on access to neurologic care and treatments. Finally, there is expanded discussion of progressive forms of MS both from a basic science and treatment perspective.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Cover -- Primer on Multiple Sclerosis -- Copyright -- Dedication -- Contents -- Foreword -- Preface -- Contributors -- Part I: Historical Background -- 1. The History of Multiple Sclerosis: From the Age of Description to the Age of Therapy -- Part II: Basic Science -- 2. Genetics and Epidemiology of Multiple Sclerosis -- 3. Neurophysiology of Multiple Sclerosis -- 4. Immunology of Multiple Sclerosis -- 5. Taking a Microscopic Look at Multiple Sclerosis -- Part III: Diagnosis &amp -- Prognosis -- 6. Diagnosis of Multiple Sclerosis -- 7. Neuroimaging in Multiple Sclerosis -- 8. The Importance and Utility of Cerebrospinal Fluid Evaluation in the Diagnosis of Central Demyelinating Diseases -- 9. Evoked Potentials -- 10. Temporal and Clinical Course of Multiple Sclerosis -- 11. Outcome Measures in Multiple Sclerosis -- Part IV: Clinical Manifestations -- 12. Neuro-ophthalmologic Manifestations of Multiple Sclerosis -- 13. Cerebellar and Brainstem Dysfunction in Multiple Sclerosis -- 14. Disorders of Mobility in Multiple Sclerosis -- 15. Management of Urinary and Bowel Dysfunction in Multiple Sclerosis -- 16. Assessment and Treatment of Sexual Dysfunction in Multiple Sclerosis -- 17. Gender and Reproductive Issues in Multiple Sclerosis -- 18. Cognitive Impairment and Mood Disturbances -- 19. Multiple Sclerosis and Pain -- 20. Fatigue in Multiple Sclerosis -- 21. Sleep Disorders in Multiple Sclerosis -- 22. Pediatric Multiple Sclerosis -- 23. Neuromyelitis Optica Spectrum Disorders -- 24. Multiple Sclerosis Nursing -- Part V: Therapeutics -- 25. Immunomodulatory Agents for Relapsing-Remitting Multiple Sclerosis -- 26. Relapses, Immunosuppressive and Novel Therapies -- 27. Complementary and Alternative Medicine in Multiple Sclerosis -- Part VI: Psychosocial Issues.

28. Living with Multiple Sclerosis: The Psychosocial Challenges for Patients and Their Families -- 29. Employment and Career Development Considerations -- 30. Legal Planning Issues -- Part VII: Research -- 31. Issues in the Design and Interpretation of Multiple Sclerosis Clinical Trials -- 32. Basic Science in Multiple Sclerosis Research: Progress and Promise -- Index.

In this second edition of Primer on Multiple Sclerosis, the latest updates on therapeutics will be provided, including new medications that have been FDA- approved since the first edition. New diagnostic criteria is included, as well as any advances made in current diagnostic techniques, e.g. new imaging metrics. Important new information in the basic sciences and pathophysiology of MS are provided as well as newer epidemiologic studies. Treatment algorithms for common symptoms will be expanded, as well as any new guidelines for switching medications for Disease Modifying treatment "failures". The chapter on alternative and complimentary therapies will discuss new research on CCSVI. The chapter on legal issues will include information on the putative effect of the Affordable Health Care Act on access to neurologic care and treatments. Finally, there is expanded discussion of progressive forms of MS both from a basic science and treatment perspective.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.